Search research articles
Contact Us
Filters
Showing results (581-590 of 626) with videos related to
Page
of 63
Sort By:
EJNMMI Radiopharmacy and Chemistry
|
March 26, 2026
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Oliver C Kiss, Ivan Penuelas, Ana Rey, et al.
Journal of Hepatology
|
April 23, 2023
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming
Beatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
Journal of Hepatology
|
February 26, 2022
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models
Paula Olaizola, Pui Yuen Lee-Law, Maite G Fernandez-Barrena, et al.
Hepatology (Baltimore, Md.)
|
February 11, 2025
Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talk
Paula Olaizola, Irene Olaizola, Marta Fernandez de Ara, et al.
Cancers
|
January 11, 2022
Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease
Chaobo Chen, Hanghang Wu, Hui Ye, et al.
International Journal of Molecular Sciences
|
December 2, 2020
Multi-Omics Integration Highlights the Role of Ubiquitination in CCl<sub>4</sub>-Induced Liver Fibrosis
Maria Mercado-Gómez, Fernando Lopitz-Otsoa, Mikel Azkargorta, et al.
Cell Death & Disease
|
September 22, 2018
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
David Fernández-Ramos, Pablo Fernández-Tussy, Fernando Lopitz-Otsoa, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 14, 2025
Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma
Daniel Oyon, Amaya Lopez-Pascual, Borja Castello-Uribe, et al.
Gut
|
July 21, 2021
Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures
Maria Arechederra, María Rullán, Irene Amat, et al.
Cell Reports. Medicine
|
April 2, 2026
Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma
Elena Adan-Villaescusa, Borja Castello-Uribe, Iker Uriarte, et al.
Page
of 63
Search research articles
Search
Showing results (581-590 of 626) with videos related to
Sort By:
Page
of 63
EJNMMI Radiopharmacy and Chemistry
|
March 26, 2026
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Oliver C Kiss, Ivan Penuelas, Ana Rey, et al.
Journal of Hepatology
|
April 23, 2023
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming
Beatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
Journal of Hepatology
|
February 26, 2022
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models
Paula Olaizola, Pui Yuen Lee-Law, Maite G Fernandez-Barrena, et al.
Hepatology (Baltimore, Md.)
|
February 11, 2025
Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talk
Paula Olaizola, Irene Olaizola, Marta Fernandez de Ara, et al.
Cancers
|
January 11, 2022
Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease
Chaobo Chen, Hanghang Wu, Hui Ye, et al.
International Journal of Molecular Sciences
|
December 2, 2020
Multi-Omics Integration Highlights the Role of Ubiquitination in CCl<sub>4</sub>-Induced Liver Fibrosis
Maria Mercado-Gómez, Fernando Lopitz-Otsoa, Mikel Azkargorta, et al.
Cell Death & Disease
|
September 22, 2018
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
David Fernández-Ramos, Pablo Fernández-Tussy, Fernando Lopitz-Otsoa, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 14, 2025
Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma
Daniel Oyon, Amaya Lopez-Pascual, Borja Castello-Uribe, et al.
Gut
|
July 21, 2021
Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures
Maria Arechederra, María Rullán, Irene Amat, et al.
Cell Reports. Medicine
|
April 2, 2026
Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma
Elena Adan-Villaescusa, Borja Castello-Uribe, Iker Uriarte, et al.
Page
of 63